RhumbLine Advisers
ACLX

RhumbLine Advisers’s Arcellx ACLX Stock Holding History

RhumbLine Advisers’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.19M Buy
45,211
+859
+2% +$75.8K ﹤0.01% 1387
2025
Q4 		$2.89M Sell
44,352
-8,076
-15% -$644K ﹤0.01% 1675
2025
Q3 		$4.3M Sell
52,428
-2,712
-5% -$195K ﹤0.01% 1509
2025
Q2 		$3.63M Sell
55,140
-8,611
-14% -$536K ﹤0.01% 1581
2025
Q1 		$4.18M Buy
63,751
+3,848
+6% +$261K ﹤0.01% 1449
2024
Q4 		$4.59M Buy
59,903
+1,125
+2% +$97.2K ﹤0.01% 1464
2024
Q3 		$4.91M Sell
58,778
-1,792
-3% -$119K ﹤0.01% 1437
2024
Q2 		$3.34M Buy
60,570
+7,568
+14% +$411K ﹤0.01% 1615
2024
Q1 		$3.69M Buy
53,002
+1,567
+3% +$99.4K ﹤0.01% 1581
2023
Q4 		$2.85M Buy
51,435
+83
+0.2% +$3.74K ﹤0.01% 1722
2023
Q3 		$1.84M Buy
51,352
+923
+2% +$31.8K ﹤0.01% 1896
2023
Q2 		$1.59M Buy
50,429
+3,915
+8% +$150K ﹤0.01% 2034
2023
Q1 		$1.43M Buy
46,514
+3,525
+8% +$107K ﹤0.01% 1976
2022
Q4 		$1.33M Buy
42,989
+5,066
+13% +$116K ﹤0.01% 2000
2022
Q3 		$712K Buy
37,923
+23,325
+160% +$446K ﹤0.01% 2329
2022
Q2 		$264K Buy
+14,598
New +$188K ﹤0.01% 2823

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

RhumbLine Advisers's ACLX Position: Q1 2026 in Review

RhumbLine Advisers increased its Arcellx (ACLX) stake by 1.9% in Q1 2026, buying an estimated $75.8K and bringing the position to 45,211 shares worth $5.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1387.

RhumbLine Advisers first reported a position in ACLX in Q2 2022 and has held it in 16 quarters since. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • RhumbLine Advisers held 45,211 shares of Arcellx worth $5.19M as of Q1 2026.
  • RhumbLine Advisers bought 859 Arcellx shares in Q1 2026, an estimated $75.8K.
  • Arcellx made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #1387 holding.
  • RhumbLine Advisers first reported a position in Arcellx in Q2 2022 and has held it in 16 quarters since.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.